Cas:883028-08-8 2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole manufacturer & supplier

We serve Chemical Name:2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole CAS:883028-08-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole

Chemical Name:2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole
CAS.NO:883028-08-8
Synonyms:hms1448e01
Molecular Formula:C14H10ClNO
Molecular Weight:243.68800
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.03000
Exact Mass:243.04500
LogP:4.45660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like hms1448e01 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,hms1448e01 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hms1448e01 Use and application,hms1448e01 technical grade,usp/ep/jp grade.


Related News: CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. 2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole manufacturer The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole supplier The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole vendor Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. 2-(3-Chlorophenyl)-5-methyl-1,3-benzoxazole factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.